Announcement no. 30/2022
16 May 2022
Transactions in relation to share buyback program
On 14 February 2022, Össur hf. initiated a share buyback program ("Program"), see Company Announcement no. 05/2022.
The purpose of the Program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Capital Allocation Policy. The Program will end no later than 23 December 2022, but the Company is entitled to discontinue the Program at any time. The Company may purchase up to 2,000,000 shares under the Program, corresponding to 0.47% of the current share capital. The total consideration for shares purchased under the Program shall not exceed USD 10 million.
The following transactions have been made under the Program in the period 9 May 2022 - 12 May 2022.
Date No. of Avg. purchase Transaction
shares price in DKK value in DKK
9 May 2022 10,850 32.28 350,269
10 May 2022 4,902 31.34 153,625
11 May 2022 10,160 31.23 317,325
12 May 2022 29,628 33.05 979,208
Total 55,540 32.42 1,800,428
Össur has acquired 823,181 shares under the Program at the average price of DKK 37.25. Following the above transactions, Össur holds 1,449,548 shares, corresponding to 0.34% of the Company's total share capital.
The Program on Nasdaq Copenhagen is carried out in accordance with Regulation No. 596/2014 of the European Parliament and of the Council on market abuse ("MAR"), and the Commission's delegated regulation 2016/1052.
Edda Lára Lúðvígsdóttir, Investor Relations Director, firstname.lastname@example.org,+354 844 4759
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail, please register at http://www.ossur.com/investors
Össur (Nasdaq Copenhagen: OSSR) is a global leader in non-invasive orthopaedics that helps people live a Life Without Limitations. A recognized "Technology Pioneer" with a rich 50-year history, Össur focuses on improving people's mobility through the delivery of innovative technologies in Prosthetics and Bracing & Supports. Significant investment in research and development have led to over 2,000 patents, award-winning designs, successful clinical outcomes, and consistently strong market positions. Össur is signatory to the UN Global Compact, UN Women's Empowerment Principles, contributes to the UN Sustainable Development Goals and became Carbon Neutral in 2021. Össur operates globally and employs around 4,000 employees. www.ossur.com
This information was distributed by Cision http://www.cisionwire.se/